Marsh encourages customers to clean out medicine cabinets
INDIANAPOLIS — Marsh Supermarkets is inviting customers to properly dispose of their unused, unwanted and/or expired medications.
From Sept. 21 to 24, Marsh pharmacies will collect and qualify unwanted medications for free disposal. Pills, capsules and liquids are accepted for disposal, and the medicine must be in original container with original label intact, Marsh said.
The takeback program is brought in partnership with such private and public organizations as Indiana University Health, the Indiana Department of Environmental Management, Indiana Poison Center, Indiana Association for Home and Hospice Care, packaging company Rexam and solutions firm Inmar. Marsh also noted that the program is for individuals only, and that nothing will be accepted from health centers, clinics, doctor’s offices or other organizations.
Target store to debut in East Peoria, Ill.
MINNEAPOLIS — Target is slated to open a new store in East Peoria, Ill., making it the first Target store in the city.
The 135,000-sq.-ft. store, which will be part of the 86-acre East Peoria Downtown development, will include a selection of fresh produce, fresh packaged meat and prepackaged baked goods, as well as a Starbucks and a Target pharmacy. The East Peoria Target will open in March 2013.
"Target is excited to open its first store in East Peoria," said Bryan Everett, Target SVP stores in the Midwest. "We are committed to being a good neighbor to the East Peoria and surrounding Illinois communities, and to developing long-lasting relationships with our guests."
Vivus launches obesity drug
MOUNTAIN VIEW, Calif. — Drug maker Vivus has released what it called the first new drug in 13 years for chronic weight management in adults.
The company announced the availability of Qsymia (phentermine and topiramate) extended-release capsules, which it is formally introducing to medical professionals this week at the Obesity Society’s annual scientific meeting in San Antonio.
"Vivus is proud to be leading the way in the treatment of obesity, a disease with very serious health consequences," Vivus president Peter Tam said. "Qsymia is the first ever combination treatment made available, and today’s introduction marks a new beginning for many patients who struggle with obesity."
The drug, which is classified as a schedule IV controlled substance by the Drug Enforcement Administration, has a risk evaluation and mitigation strategy, or REMS. In addition to a medication guide, healthcare provider training, patient brochure and other educational materials, the drug is only available through certified mail-order pharmacies that are part of the Qsymia Home Delivery Network, including CVS Pharmacy and Walgreens.